{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:15:11Z","timestamp":1781712911630,"version":"3.54.5"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Fundamental Research Funds for the Central Universities","award":["2025ZFJH03"],"award-info":[{"award-number":["2025ZFJH03"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["226-2025-00249"],"award-info":[{"award-number":["226-2025-00249"]}]},{"name":"the Central Guidance Fund for Local Science and Technology Development","award":["2024ZY01054"],"award-info":[{"award-number":["2024ZY01054"]}]},{"name":"Key Nature Science Foundation of Zhejiang Province","award":["LZ24H160005"],"award-info":[{"award-number":["LZ24H160005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Notch signaling pathway is critical for maintaining tissue homeostasis and plays dual roles in digestive system cancers, acting both as an oncogene and a tumor suppressor gene. This article explores its varied functions across esophageal, gastric, liver, pancreatic, and colorectal cancers. In esophageal and pancreatic cancers, Notch signaling may initially inhibit tumor growth but later promote progression, influenced by the primary cell types. In hepatocellular carcinoma, DLL4\/Notch1 generally drives tumor growth, whereas Jag1\/Notch2 tends to suppress tumor progression. In colon cancer, this pathway not only facilitates immune evasion but, in the presence of specific mutations, can also enhance the anti-tumor immune response. The functional complexity of Notch signaling presents significant therapeutic challenges, as broad-spectrum \u03b3-secretase inhibitors (GSIs) are often associated with considerable side effects. Future treatment strategies should prioritize precision medicine, including subtype-specific Notch receptor inhibitors, biomarker-driven personalized therapies, and combination treatments aimed at modifying the tumor microenvironment. A thorough understanding of these dual roles is significant for developing more accurate and effective treatment approaches for digestive system cancers.<\/jats:p>","DOI":"10.1186\/s40001-026-03947-3","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T03:46:37Z","timestamp":1769485597000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The dual role of the Notch signaling pathway in digestive system cancers"],"prefix":"10.1186","volume":"31","author":[{"given":"Dairong","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuokai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"1","key":"3947_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01640-8","volume":"17","author":"Z Wu","year":"2024","unstructured":"Wu Z, Xia F, Lin R. Global burden of cancer and associated risk factors in 204 countries and territories, 1980\u20132021: a systematic analysis for the GBD 2021. J Hematol Oncol. 2024;17(1):119. https:\/\/doi.org\/10.1186\/s13045-024-01640-8.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"3947_CR2","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2174\/0109298665350654250111144722","volume":"32","author":"Q Suyila","year":"2025","unstructured":"Suyila Q, Li X, Su X. Anti-cancer bioactive peptide induces apoptosis in gastric cancer cells through TP53 signaling cascade. Protein Pept Lett. 2025;32(3):194\u2013205. https:\/\/doi.org\/10.2174\/0109298665350654250111144722.","journal-title":"Protein Pept Lett"},{"issue":"3","key":"3947_CR3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/stem.1031","volume":"30","author":"AG Vaiopoulos","year":"2012","unstructured":"Vaiopoulos AG, Kostakis ID, Koutsilieris M, Papavassiliou AG. Colorectal cancer stem cells. Stem Cells. 2012;30(3):363\u201371. https:\/\/doi.org\/10.1002\/stem.1031.","journal-title":"Stem Cells"},{"key":"3947_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-5-63","volume":"5","author":"W Sun","year":"2012","unstructured":"Sun W. Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy. J Hematol Oncol. 2012;5:63. https:\/\/doi.org\/10.1186\/1756-8722-5-63.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"3947_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02622-3","volume":"42","author":"HJ Lim","year":"2023","unstructured":"Lim HJ, Zhuang L, Fitzgerald RC. Current advances in understanding the molecular profile of hereditary diffuse gastric cancer and its clinical implications. J Exp Clin Cancer Res. 2023;42(1):57. https:\/\/doi.org\/10.1186\/s13046-023-02622-3.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"3947_CR6","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1517\/17460441.2013.807249","volume":"8","author":"JC Curtin","year":"2013","unstructured":"Curtin JC. Novel drug discovery opportunities for colorectal cancer. Expert Opin Drug Discov. 2013;8(9):1153\u201364. https:\/\/doi.org\/10.1517\/17460441.2013.807249.","journal-title":"Expert Opin Drug Discov"},{"issue":"4","key":"3947_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2174\/0115665232320846240910055032","volume":"25","author":"M Dwivedi","year":"2025","unstructured":"Dwivedi M, Sanyal S, Singh S, Dwivedi M, Sanyal S. Target and gene-based therapeutic strategies against pancreatic cancer: current and future prospects. Curr Gene Ther. 2025;25(4):417\u201332. https:\/\/doi.org\/10.2174\/0115665232320846240910055032.","journal-title":"Curr Gene Ther"},{"key":"3947_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101098","volume":"75","author":"Z Xu","year":"2024","unstructured":"Xu Z, Zhou H, Li T, Yi Q, Thakur A, Zhang K, et al. Application of biomimetic nanovaccines in cancer immunotherapy: a useful strategy to help combat immunotherapy resistance. Drug Resist Updat. 2024;75:101098. https:\/\/doi.org\/10.1016\/j.drup.2024.101098.","journal-title":"Drug Resist Updat"},{"key":"3947_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107975","volume":"221","author":"X Wang","year":"2025","unstructured":"Wang X, Wang C, Liu W, Thakur A, Zhang K, Xu Z, et al. The roles of ultrasound-responsive nanomaterials in enhancing cancer immunotherapy. Pharmacol Res. 2025;221:107975. https:\/\/doi.org\/10.1016\/j.phrs.2025.107975.","journal-title":"Pharmacol Res"},{"issue":"2","key":"3947_CR10","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cell.2009.03.045","volume":"137","author":"R Kopan","year":"2009","unstructured":"Kopan R, Ilagan MX. The canonical notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137(2):216\u201333. https:\/\/doi.org\/10.1016\/j.cell.2009.03.045.","journal-title":"Cell"},{"key":"3947_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2148-9-249","volume":"9","author":"E Gazave","year":"2009","unstructured":"Gazave E, Lap\u00e9bie P, Richards GS, Brunet F, Ereskovsky AV, Degnan BM, et al. Origin and evolution of the Notch signalling pathway: an overview from eukaryotic genomes. BMC Evol Biol. 2009;9:249. https:\/\/doi.org\/10.1186\/1471-2148-9-249.","journal-title":"BMC Evol Biol"},{"issue":"1","key":"3947_CR12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.ydbio.2006.11.022","volume":"303","author":"T K\u00e4sbauer","year":"2007","unstructured":"K\u00e4sbauer T, Towb P, Alexandrova O, David CN, Dall\u2019Armi E, Staudigl A, et al. The Notch signaling pathway in the cnidarian hydra. Dev Biol. 2007;303(1):376\u201390. https:\/\/doi.org\/10.1016\/j.ydbio.2006.11.022.","journal-title":"Dev Biol"},{"issue":"5415","key":"3947_CR13","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1126\/science.284.5415.770","volume":"284","author":"S Artavanis-Tsakonas","year":"1999","unstructured":"Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science. 1999;284(5415):770\u20136. https:\/\/doi.org\/10.1126\/science.284.5415.770.","journal-title":"Science"},{"issue":"4","key":"3947_CR14","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41559-019-1069-x","volume":"4","author":"R Fern\u00e1ndez","year":"2020","unstructured":"Fern\u00e1ndez R, Gabald\u00f3n T. Gene gain and loss across the metazoan tree of life. Nat Ecol Evol. 2020;4(4):524\u201333. https:\/\/doi.org\/10.1038\/s41559-019-1069-x.","journal-title":"Nat Ecol Evol"},{"issue":"1","key":"3947_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20023-4","volume":"11","author":"GA Cary","year":"2020","unstructured":"Cary GA, McCauley BS, Zueva O, Pattinato J, Longabaugh W, Hinman VF. Systematic comparison of sea urchin and sea star developmental gene regulatory networks explains how novelty is incorporated in early development. Nat Commun. 2020;11(1):6235. https:\/\/doi.org\/10.1038\/s41467-020-20023-4.","journal-title":"Nat Commun"},{"issue":"2","key":"3947_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2174\/0115665232258527230919071328","volume":"24","author":"Y Ning","year":"2024","unstructured":"Ning Y, Zhou X, Wang G, Zhang L, Wang J. Exosome miR-30a-5p regulates glomerular endothelial cells\u2019 EndMT and angiogenesis by modulating Notch1\/VEGF signaling pathway. Curr Gene Ther. 2024;24(2):159\u201377. https:\/\/doi.org\/10.2174\/0115665232258527230919071328.","journal-title":"Curr Gene Ther"},{"issue":"12","key":"3947_CR17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1073\/pnas.3.12.673","volume":"3","author":"CW Metz","year":"1917","unstructured":"Metz CW, Bridges CB. Incompatibility of mutant races in Drosophila. Proc Natl Acad Sci USA. 1917;3(12):673\u20138. https:\/\/doi.org\/10.1073\/pnas.3.12.673.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"3947_CR18","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.80.7.1977","volume":"80","author":"S Artavanis-Tsakonas","year":"1983","unstructured":"Artavanis-Tsakonas S, Muskavitch MA, Yedvobnick B. Molecular cloning of Notch, a locus affecting neurogenesis in Drosophila melanogaster. Proc Natl Acad Sci USA. 1983;80(7):1977\u201381. https:\/\/doi.org\/10.1073\/pnas.80.7.1977.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"3947_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00934-y","volume":"7","author":"B Zhou","year":"2022","unstructured":"Zhou B, Lin W, Long Y, Yang Y, Zhang H, Wu K, et al. Notch signaling pathway: architecture, disease, and therapeutics. Signal Transduct Target Ther. 2022;7(1):95. https:\/\/doi.org\/10.1038\/s41392-022-00934-y.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3947_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/0113892029273682240111052317","volume":"25","author":"R Mu","year":"2024","unstructured":"Mu R, Chang M, Feng C, Cui Y, Li T, Liu C, et al. Analysis of the expression of PRDX6 in patients with hepatocellular carcinoma and its effect on the phenotype of hepatocellular carcinoma cells. Curr Genomics. 2024;25(1):2\u201311. https:\/\/doi.org\/10.2174\/0113892029273682240111052317.","journal-title":"Curr Genomics"},{"issue":"1","key":"3947_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01828-x","volume":"9","author":"Q Shi","year":"2024","unstructured":"Shi Q, Xue C, Zeng Y, Yuan X, Chu Q, Jiang S, et al. Notch signaling pathway in cancer: from mechanistic insights to targeted therapies. Signal Transduct Target Ther. 2024;9(1):128. https:\/\/doi.org\/10.1038\/s41392-024-01828-x.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3947_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01439-z","volume":"16","author":"X Li","year":"2023","unstructured":"Li X, Yan X, Wang Y, Kaur B, Han H, Yu J. The Notch signaling pathway: a potential target for cancer immunotherapy. J Hematol Oncol. 2023;16(1):45. https:\/\/doi.org\/10.1186\/s13045-023-01439-z.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"3947_CR23","doi-asserted-by":"publisher","first-page":"224","DOI":"10.2174\/0109298665359781250114055525","volume":"32","author":"X Luo","year":"2025","unstructured":"Luo X, Gao Z. MARVELD1 promotes the invasiveness in pancreatic adenocarcinoma through the activation of epithelial-to-mesenchymal transition. Protein Pept Lett. 2025;32(3):224\u201333. https:\/\/doi.org\/10.2174\/0109298665359781250114055525.","journal-title":"Protein Pept Lett"},{"issue":"1","key":"3947_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2174\/1874467215666220408104341","volume":"16","author":"PR Farnood","year":"2023","unstructured":"Farnood PR, Pazhooh RD, Asemi Z, Yousefi B. Targeting signaling pathway by curcumin in osteosarcoma. Curr Mol Pharmacol. 2023;16(1):71\u201382. https:\/\/doi.org\/10.2174\/1874467215666220408104341.","journal-title":"Curr Mol Pharmacol"},{"key":"3947_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101105","volume":"26","author":"Y Sun","year":"2024","unstructured":"Sun Y, Zhang W, Lu Y, He Y, Yahaya B, Liu Y, et al. An artificial signaling pathway, primitive-based intelligent biomimetic nanoenzymes carrier platform for precise treatment of Her2 (+) tumors. Mater Today Bio. 2024;26:101105. https:\/\/doi.org\/10.1016\/j.mtbio.2024.101105.","journal-title":"Mater Today Bio"},{"issue":"4","key":"3947_CR26","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/0092-8674(91)90111-b","volume":"66","author":"LW Ellisen","year":"1991","unstructured":"Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD, et al. TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell. 1991;66(4):649\u201361. https:\/\/doi.org\/10.1016\/0092-8674(91)90111-b.","journal-title":"Cell"},{"issue":"43","key":"3947_CR27","doi-asserted-by":"publisher","first-page":"17761","DOI":"10.1073\/pnas.1114669108","volume":"108","author":"NJ Wang","year":"2011","unstructured":"Wang NJ, Sanborn Z, Arnett KL, Bayston LJ, Liao W, Proby CM, et al. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc Natl Acad Sci. 2011;108(43):17761\u20136. https:\/\/doi.org\/10.1073\/pnas.1114669108.","journal-title":"Proc Natl Acad Sci"},{"issue":"12","key":"3947_CR28","doi-asserted-by":"publisher","first-page":"8442","DOI":"10.1074\/jbc.M113.516039","volume":"289","author":"J Ma","year":"2014","unstructured":"Ma J, Tang X, Wong P, Jacobs B, Borden EC, Bedogni B. Noncanonical activation of Notch1 protein by membrane type 1 matrix metalloproteinase (MT1-MMP) controls melanoma cell proliferation. J Biol Chem. 2014;289(12):8442\u20139. https:\/\/doi.org\/10.1074\/jbc.M113.516039.","journal-title":"J Biol Chem"},{"key":"3947_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms16074","volume":"8","author":"S Lin","year":"2017","unstructured":"Lin S, Negulescu A, Bulusu S, Gibert B, Delcros J-G, Ducarouge B, et al. Non-canonical NOTCH3 signalling limits tumour angiogenesis. Nat Commun. 2017;8:16074. https:\/\/doi.org\/10.1038\/ncomms16074.","journal-title":"Nat Commun"},{"issue":"5","key":"3947_CR30","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2174\/0115665232331353240911080642","volume":"25","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Zhao Z, Huang W, Kim BS, Lin L, Li X, et al. Pan-cancer single-cell analysis revealing the heterogeneity of cancer- associated fibroblasts in skin tumors. Curr Gene Ther. 2025;25(5):793\u2013821. https:\/\/doi.org\/10.2174\/0115665232331353240911080642.","journal-title":"Curr Gene Ther"},{"issue":"7","key":"3947_CR31","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/carcin\/bgt127","volume":"34","author":"KM Capaccione","year":"2013","unstructured":"Capaccione KM, Pine SR. The Notch signaling pathway as a mediator of tumor survival. Carcinogenesis. 2013;34(7):1420\u201330. https:\/\/doi.org\/10.1093\/carcin\/bgt127.","journal-title":"Carcinogenesis"},{"issue":"5","key":"3947_CR32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.sbi.2011.08.008","volume":"21","author":"NA Rana","year":"2011","unstructured":"Rana NA, Haltiwanger RS. Fringe benefits: functional and structural impacts of O-glycosylation on the extracellular domain of Notch receptors. Curr Opin Struct Biol. 2011;21(5):583\u20139. https:\/\/doi.org\/10.1016\/j.sbi.2011.08.008.","journal-title":"Curr Opin Struct Biol"},{"issue":"3","key":"3947_CR33","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.devcel.2017.04.001","volume":"41","author":"RA Kovall","year":"2017","unstructured":"Kovall RA, Gebelein B, Sprinzak D, Kopan R. The canonical Notch signaling pathway: structural and biochemical insights into shape, sugar, and force. Dev Cell. 2017;41(3):228\u201341. https:\/\/doi.org\/10.1016\/j.devcel.2017.04.001.","journal-title":"Dev Cell"},{"issue":"18","key":"3947_CR34","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1182\/blood-2008-08-174748","volume":"113","author":"WR Gordon","year":"2009","unstructured":"Gordon WR, Roy M, Vardar-Ulu D, Garfinkel M, Mansour MR, Aster JC, et al. Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL. Blood. 2009;113(18):4381\u201390. https:\/\/doi.org\/10.1182\/blood-2008-08-174748.","journal-title":"Blood"},{"issue":"41","key":"3947_CR35","doi-asserted-by":"publisher","first-page":"E2757","DOI":"10.1073\/pnas.1205788109","volume":"109","author":"NL Stephenson","year":"2012","unstructured":"Stephenson NL, Avis JM. Direct observation of proteolytic cleavage at the S2 site upon forced unfolding of the Notch negative regulatory region. Proc Natl Acad Sci. 2012;109(41):E2757\u201365. https:\/\/doi.org\/10.1073\/pnas.1205788109.","journal-title":"Proc Natl Acad Sci"},{"issue":"12","key":"3947_CR36","doi-asserted-by":"publisher","first-page":"8046","DOI":"10.1074\/jbc.M800170200","volume":"283","author":"K Li","year":"2008","unstructured":"Li K, Li Y, Wu W, Gordon WR, Chang DW, Lu M, et al. Modulation of Notch signaling by antibodies specific for the extracellular negative regulatory region of NOTCH3. J Biol Chem. 2008;283(12):8046\u201354. https:\/\/doi.org\/10.1074\/jbc.M800170200.","journal-title":"J Biol Chem"},{"issue":"5","key":"3947_CR37","doi-asserted-by":"publisher","first-page":"363","DOI":"10.5582\/bst.2022.01394","volume":"16","author":"W Jiang","year":"2022","unstructured":"Jiang W, Yu J, Cao M, Xiao B, Li F, Chen C, et al. Notch signaling pathway plays a critical role in chemotherapeutic drug-induced vestibular injury. Biosci Trends. 2022;16(5):363\u20136. https:\/\/doi.org\/10.5582\/bst.2022.01394.","journal-title":"Biosci Trends"},{"issue":"4","key":"3947_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06512-0","volume":"15","author":"SS Islam","year":"2024","unstructured":"Islam SS, Al-Mohanna FH, Yousef IM, Al-Badawi IA, Aboussekhra A. Ovarian tumor cell-derived JAGGED2 promotes omental metastasis through stimulating the Notch signaling pathway in the mesothelial cells. Cell Death Dis. 2024;15(4):247. https:\/\/doi.org\/10.1038\/s41419-024-06512-0.","journal-title":"Cell Death Dis"},{"key":"3947_CR39","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0070-2153(10)92003-6","volume":"92","author":"B D\u2019Souza","year":"2010","unstructured":"D\u2019Souza B, Meloty-Kapella L, Weinmaster G. Canonical and non-canonical Notch ligands. Curr Top Dev Biol. 2010;92:73\u2013129. https:\/\/doi.org\/10.1016\/S0070-2153(10)92003-6.","journal-title":"Curr Top Dev Biol"},{"issue":"12","key":"3947_CR40","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.tem.2021.08.002","volume":"32","author":"GE Moldovan","year":"2021","unstructured":"Moldovan GE, Miele L, Fazleabas AT. Notch signaling in reproduction. Trends Endocrinol Metab. 2021;32(12):1044\u201357. https:\/\/doi.org\/10.1016\/j.tem.2021.08.002.","journal-title":"Trends Endocrinol Metab"},{"key":"3947_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-biophys-101920-082204","volume":"50","author":"D Sprinzak","year":"2021","unstructured":"Sprinzak D, Blacklow SC. Biophysics of Notch signaling. Annu Rev Biophys. 2021;50:157\u201389. https:\/\/doi.org\/10.1146\/annurev-biophys-101920-082204.","journal-title":"Annu Rev Biophys"},{"key":"3947_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/bs.ircmb.2023.11.006","volume":"385","author":"A Ahmad","year":"2024","unstructured":"Ahmad A, Tiwari KB, Siddiqui S, Chadha M, Shukla R, Srivastava V. Emerging trends in gastrointestinal cancers: targeting developmental pathways in carcinogenesis and tumor progression. Int Rev Cell Mol Biol. 2024;385:41\u201399. https:\/\/doi.org\/10.1016\/bs.ircmb.2023.11.006.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"22","key":"3947_CR43","doi-asserted-by":"publisher","first-page":"16113","DOI":"10.3390\/ijms242216113","volume":"24","author":"PM Tricarico","year":"2023","unstructured":"Tricarico PM, Crovella S. Notch signaling in health and disease. Int J Mol Sci. 2023;24(22):16113. https:\/\/doi.org\/10.3390\/ijms242216113.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3947_CR44","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1517\/14728221003752750","volume":"14","author":"D Ma","year":"2010","unstructured":"Ma D, Zhu Y, Ji C, Hou M. Targeting the Notch signaling pathway in autoimmune diseases. Expert Opin Ther Targets. 2010;14(5):553\u201365. https:\/\/doi.org\/10.1517\/14728221003752750.","journal-title":"Expert Opin Ther Targets"},{"issue":"12","key":"3947_CR45","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.3324\/haematol.2011.055954","volume":"96","author":"R Schwanbeck","year":"2011","unstructured":"Schwanbeck R, Just U. The Notch signaling pathway in hematopoiesis and hematologic malignancies. Haematologica. 2011;96(12):1735\u20137. https:\/\/doi.org\/10.3324\/haematol.2011.055954.","journal-title":"Haematologica"},{"issue":"8","key":"3947_CR46","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ajpath.2019.05.005","volume":"189","author":"Z Luo","year":"2019","unstructured":"Luo Z, Shang X, Zhang H, Wang G, Massey PA, Barton SR, et al. Notch signaling in osteogenesis, osteoclastogenesis, and angiogenesis. Am J Pathol. 2019;189(8):1495\u2013500. https:\/\/doi.org\/10.1016\/j.ajpath.2019.05.005.","journal-title":"Am J Pathol"},{"issue":"6683","key":"3947_CR47","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/30756","volume":"393","author":"EH Schroeter","year":"1998","unstructured":"Schroeter EH, Kisslinger JA, Kopan R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature. 1998;393(6683):382\u20136. https:\/\/doi.org\/10.1038\/30756.","journal-title":"Nature"},{"issue":"1","key":"3947_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01996-x","volume":"23","author":"PS Jeong","year":"2025","unstructured":"Jeong PS, Kang HG, Cha D, Jeon SB, Kim MJ, Song BS, et al. Role of the Notch signaling pathway in porcine oocyte maturation. Cell Commun Signal. 2025;23(1):1. https:\/\/doi.org\/10.1186\/s12964-024-01996-x.","journal-title":"Cell Commun Signal"},{"issue":"9","key":"3947_CR49","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.7150\/thno.72966","volume":"12","author":"I Krossa","year":"2022","unstructured":"Krossa I, Strub T, Martel A, Nahon-Esteve S, Lassalle S, Hofman P, et al. Recent advances in understanding the role of HES6 in cancers. Theranostics. 2022;12(9):4374\u201385. https:\/\/doi.org\/10.7150\/thno.72966.","journal-title":"Theranostics"},{"key":"3947_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.101041","volume":"57","author":"K Yao","year":"2024","unstructured":"Yao K, Zhan XY, Feng M, Yang KF, Zhou MS, Jia H. Furin, ADAM, and \u03b3-secretase: core regulatory targets in the Notch pathway and the therapeutic potential for breast cancer. Neoplasia. 2024;57:101041. https:\/\/doi.org\/10.1016\/j.neo.2024.101041.","journal-title":"Neoplasia"},{"issue":"12","key":"3947_CR51","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1038\/s44321-024-00161-8","volume":"16","author":"M Fournier","year":"2024","unstructured":"Fournier M, Javary J, Roh V, Fournier N, Radtke F. Reciprocal inhibition of NOTCH and SOX2 shapes tumor cell plasticity and therapeutic escape in triple-negative breast cancer. EMBO Mol Med. 2024;16(12):3184\u2013217. https:\/\/doi.org\/10.1038\/s44321-024-00161-8.","journal-title":"EMBO Mol Med"},{"issue":"2","key":"3947_CR52","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41588-022-01280-z","volume":"55","author":"E Abby","year":"2023","unstructured":"Abby E, Dentro SC, Hall MWJ, Fowler JC, Ong SH, Sood R, et al. Notch1 mutations drive clonal expansion in normal esophageal epithelium but impair tumor growth. Nat Genet. 2023;55(2):232\u201345. https:\/\/doi.org\/10.1038\/s41588-022-01280-z.","journal-title":"Nat Genet"},{"issue":"12","key":"3947_CR53","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.7150\/ijbs.61117","volume":"17","author":"Z Zheng","year":"2021","unstructured":"Zheng Z, Zhang B, Yu H, Li S, Song N, Jin X, et al. UBE3A activates the NOTCH pathway and promotes esophageal cancer progression by degradation of ZNF185. Int J Biol Sci. 2021;17(12):3024\u201335. https:\/\/doi.org\/10.7150\/ijbs.61117.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"3947_CR54","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ccr.2008.06.005","volume":"14","author":"S Ansieau","year":"2008","unstructured":"Ansieau S, Bastid J, Doreau A, Morel A-P, Bouchet BP, Thomas C, et al. Induction of emt by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell. 2008;14(1):79\u201389. https:\/\/doi.org\/10.1016\/j.ccr.2008.06.005.","journal-title":"Cancer Cell"},{"issue":"10","key":"3947_CR55","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1158\/0008-5472.CAN-09-4614","volume":"70","author":"S Ohashi","year":"2010","unstructured":"Ohashi S, Natsuizaka M, Wong GS, Michaylira CZ, Grugan KD, Stairs DB, et al. Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors. Cancer Res. 2010;70(10):4174\u201384. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-4614.","journal-title":"Cancer Res"},{"issue":"1","key":"3947_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01500-9","volume":"8","author":"M Natsuizaka","year":"2017","unstructured":"Natsuizaka M, Whelan KA, Kagawa S, Tanaka K, Giroux V, Chandramouleeswaran PM, et al. Interplay between Notch1 and Notch3 promotes emt and tumor initiation in squamous cell carcinoma. Nat Commun. 2017;8(1):1758. https:\/\/doi.org\/10.1038\/s41467-017-01500-9.","journal-title":"Nat Commun"},{"key":"3947_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1567524","volume":"16","author":"H Zhang","year":"2025","unstructured":"Zhang H, Hang W, Jing Z, Liu B, Wang X, Li Y, et al. The role of Notch signaling pathway in cancer: mechanistic insights, therapeutic potential, and clinical progress. Front Immunol. 2025;16:1567524. https:\/\/doi.org\/10.3389\/fimmu.2025.1567524.","journal-title":"Front Immunol"},{"issue":"9","key":"3947_CR58","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202154078","volume":"23","author":"K Baur","year":"2022","unstructured":"Baur K, Abdullah Y, Mandl C, H\u00f6lzl\u2010Wenig G, Shi Y, Edelkraut U, et al. A novel stem cell type at the basal side of the subventricular zone maintains adult neurogenesis. EMBO Rep. 2022;23(9):e54078. https:\/\/doi.org\/10.15252\/embr.202154078.","journal-title":"EMBO Rep"},{"issue":"1","key":"3947_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01421-9","volume":"22","author":"R Zhao","year":"2024","unstructured":"Zhao R, Hu Z, Zhang X, Huang S, Yu G, Wu Z, et al. The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors. Cell Commun Signal. 2024;22(1):68. https:\/\/doi.org\/10.1186\/s12964-023-01421-9.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"3947_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/cells10010094","volume":"10","author":"JO Misiorek","year":"2021","unstructured":"Misiorek JO, Przybyszewska-Podstawka A, Ka\u0142afut J, Paziewska B, Rolle K, Rivero-M\u00fcller A, et al. Context matters: NOTCH signatures and pathway in cancer progression and metastasis. Cells. 2021;10(1):94. https:\/\/doi.org\/10.3390\/cells10010094.","journal-title":"Cells"},{"issue":"1","key":"3947_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35557-y","volume":"13","author":"J Li","year":"2022","unstructured":"Li J, Wang Y, Luo Y, Liu Y, Yi Y, Li J, et al. USP5-beclin 1 axis overrides p53-dependent senescence and drives kras-induced tumorigenicity. Nat Commun. 2022;13(1):7799. https:\/\/doi.org\/10.1038\/s41467-022-35557-y.","journal-title":"Nat Commun"},{"issue":"2","key":"3947_CR62","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7150\/thno.27654","volume":"9","author":"J Meng","year":"2019","unstructured":"Meng J, Ai X, Lei Y, Zhong W, Qian B, Qiao K, et al. USP5 promotes epithelial\u2013mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma. Theranostics. 2019;9(2):573\u201387. https:\/\/doi.org\/10.7150\/thno.27654.","journal-title":"Theranostics"},{"issue":"1","key":"3947_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02309-5","volume":"10","author":"C Li","year":"2025","unstructured":"Li C, Wu P, Xie X, Chen X, Chen L, Zhu L, et al. Aberrant notch-signaling promotes tumor angiogenesis in esophageal squamous-cell carcinoma. Signal Transduct Target Ther. 2025;10(1):233. https:\/\/doi.org\/10.1038\/s41392-025-02309-5.","journal-title":"Signal Transduct Target Ther"},{"key":"3947_CR64","doi-asserted-by":"publisher","unstructured":"NOTCH1 mutations inhibit tumor growth in the esophageal epithelium. Cancer Discov. 13(3):OF6. https:\/\/doi.org\/10.1158\/2159-8290.CD-RW2023-014. 2023.","DOI":"10.1158\/2159-8290.CD-RW2023-014"},{"issue":"9","key":"3947_CR65","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1111\/cas.14541","volume":"111","author":"Y Baba","year":"2020","unstructured":"Baba Y, Nomoto D, Okadome K, Ishimoto T, Iwatsuki M, Miyamoto Y, et al. Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma. Cancer Sci. 2020;111(9):3132\u201341. https:\/\/doi.org\/10.1111\/cas.14541.","journal-title":"Cancer Sci"},{"issue":"1","key":"3947_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48347-5","volume":"15","author":"H Huang","year":"2024","unstructured":"Huang H, Jiang Y, Liu J, Luo D, Yuan J, Mu R, et al. Jag1\/2 maintain esophageal homeostasis and suppress foregut tumorigenesis by restricting the basal progenitor cell pool. Nat Commun. 2024;15(1):4124. https:\/\/doi.org\/10.1038\/s41467-024-48347-5.","journal-title":"Nat Commun"},{"issue":"17","key":"3947_CR67","doi-asserted-by":"publisher","DOI":"10.1172\/JCI175217","volume":"134","author":"SY Ku","year":"2024","unstructured":"Ku SY, Wang Y, Garcia MM, Yamada Y, Mizuno K, Long MD, et al. Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer. J Clin Invest. 2024;134(17):e175217. https:\/\/doi.org\/10.1172\/JCI175217.","journal-title":"J Clin Invest"},{"key":"3947_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1656370","volume":"16","author":"SS Wang","year":"2025","unstructured":"Wang SS, Lv HL, Nie RZ, Liu YP, Hou YJ, Chen C, et al. Notch signaling in cancer: metabolic reprogramming and therapeutic implications. Front Immunol. 2025;16:1656370. https:\/\/doi.org\/10.3389\/fimmu.2025.1656370.","journal-title":"Front Immunol"},{"key":"3947_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101429","volume":"30","author":"X Han","year":"2025","unstructured":"Han X, Wang X, Yan J, Song P, Wang Y, Kang Y, et al. Multifunctional biosynthesized magnetosome for multimodal imaging and combined therapy of tumor. Mater Today Bio. 2025;30:101429. https:\/\/doi.org\/10.1016\/j.mtbio.2024.101429.","journal-title":"Mater Today Bio"},{"key":"3947_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101132","volume":"27","author":"A Huang","year":"2024","unstructured":"Huang A, Li Q, Shi X, Gao J, Ma Y, Ding J, et al. An iron-containing nanomedicine for inducing deep tumor penetration and synergistic ferroptosis in enhanced pancreatic cancer therapy. Mater Today Bio. 2024;27:101132. https:\/\/doi.org\/10.1016\/j.mtbio.2024.101132.","journal-title":"Mater Today Bio"},{"key":"3947_CR71","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1158\/2326-6066.CIR-23-0037","volume":"12","author":"W Yan","year":"2024","unstructured":"Yan W, Menjivar RE, Bonilla ME, Steele NG, Kemp SB, Du W, et al. Notch signaling regulates immunosuppressive tumor-associated macrophage function in pancreatic cancer. Cancer Immunol Res. 2024;12:91\u2013106. https:\/\/doi.org\/10.1158\/2326-6066.CIR-23-0037.","journal-title":"Cancer Immunol Res"},{"issue":"9","key":"3947_CR72","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s00535-024-02120-z","volume":"59","author":"T Habu","year":"2024","unstructured":"Habu T, Kumagai S, Bando H, Fujisawa T, Mishima S, Kotani D, et al. Definitive chemoradiotherapy induces T-cell-inflamed tumor microenvironment in unresectable locally advanced esophageal squamous cell carcinoma. J Gastroenterol. 2024;59(9):798\u2013811. https:\/\/doi.org\/10.1007\/s00535-024-02120-z.","journal-title":"J Gastroenterol"},{"issue":"6","key":"3947_CR73","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3390\/antiox14060657","volume":"14","author":"A Sparaneo","year":"2025","unstructured":"Sparaneo A, Torrisi F, D\u2019Angeli F, Giurdanella G, Bravaccini S, Muscarella LA, et al. Decoding the NRF2\u2013NOTCH crosstalk in lung cancer\u2014an update. Antioxidants. 2025;14(6):657. https:\/\/doi.org\/10.3390\/antiox14060657.","journal-title":"Antioxidants"},{"issue":"1","key":"3947_CR74","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jcmgh.2021.08.012","volume":"13","author":"N Horita","year":"2022","unstructured":"Horita N, Keeley TM, Hibdon ES, Delgado E, Lafkas D, Siebel CW, et al. Delta-like 1-expressing cells at the gland base promote proliferation of gastric antral stem cells in mouse. Cell Mol Gastroenterol Hepatol. 2022;13(1):275\u201387. https:\/\/doi.org\/10.1016\/j.jcmgh.2021.08.012.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"38","key":"3947_CR75","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2101592118","volume":"118","author":"A Jaiswal","year":"2021","unstructured":"Jaiswal A, Murakami K, Elia A, Shibahara Y, Done SJ, Wood SA, et al. Therapeutic inhibition of USP9x-mediated Notch signaling in triple-negative breast cancer. Proc Natl Acad Sci. 2021;118(38):e2101592118. https:\/\/doi.org\/10.1073\/pnas.2101592118.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"3947_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33780-1","volume":"13","author":"HY Wong","year":"2022","unstructured":"Wong HY, Sheng Q, Hesterberg AB, Croessmann S, Rios BL, Giri K, et al. Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease. Nat Commun. 2022;13(1):6036. https:\/\/doi.org\/10.1038\/s41467-022-33780-1.","journal-title":"Nat Commun"},{"issue":"2","key":"3947_CR77","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41388-021-02078-9","volume":"41","author":"F Wang","year":"2022","unstructured":"Wang F, Zhang J, Tang H, Pang Y, Ke X, Peng W, et al. Nup54-induced CARM1 nuclear importation promotes gastric cancer cell proliferation and tumorigenesis through transcriptional activation and methylation of Notch2. Oncogene. 2022;41(2):246\u201359. https:\/\/doi.org\/10.1038\/s41388-021-02078-9.","journal-title":"Oncogene"},{"key":"3947_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216841","volume":"593","author":"L Wang","year":"2024","unstructured":"Wang L, Mao X, Yu X, Su J, Li Z, Chen Z, et al. FPR3 reprograms glycolytic metabolism and stemness in gastric cancer via calcium-NFATc1 pathway. Cancer Lett. 2024;593:216841. https:\/\/doi.org\/10.1016\/j.canlet.2024.216841.","journal-title":"Cancer Lett"},{"key":"3947_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111476","volume":"124","author":"Y Liu","year":"2024","unstructured":"Liu Y, Gu X, Xuan M, Lou N, Fu L, Li J, et al. Notch signaling in digestive system cancers: roles and therapeutic prospects. Cell Signal. 2024;124:111476. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111476.","journal-title":"Cell Signal"},{"issue":"9","key":"3947_CR80","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1038\/s41388-020-01579-3","volume":"40","author":"W Kang","year":"2021","unstructured":"Kang W, Zhang J, Huang T, Zhou Y, Wong CC, Chan RCK, et al. NOTCH3, a crucial target of miR-491-5p\/miR-875-5p, promotes gastric carcinogenesis by upregulating PHLDB2 expression and activating AKT pathway. Oncogene. 2021;40(9):1578\u201394. https:\/\/doi.org\/10.1038\/s41388-020-01579-3.","journal-title":"Oncogene"},{"issue":"4","key":"3947_CR81","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/j.1365-2559.2012.04274.x","volume":"61","author":"H Kang","year":"2012","unstructured":"Kang H, An H, Song J, Kim T, Heo J, Ahn D, et al. Notch3 and Jagged2 contribute to gastric cancer development and to glandular differentiation associated with MUC2 and MUC5AC expression. Histopathology. 2012;61(4):576\u201386. https:\/\/doi.org\/10.1111\/j.1365-2559.2012.04274.x.","journal-title":"Histopathology"},{"issue":"1","key":"3947_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02031-3","volume":"19","author":"J Long","year":"2021","unstructured":"Long J, Wang D, Yang X, Wang A, Lin Y, Zheng M, et al. Identification of NOTCH4 mutation as a response biomarker for immune checkpoint inhibitor therapy. BMC Med. 2021;19(1):154. https:\/\/doi.org\/10.1186\/s12916-021-02031-3.","journal-title":"BMC Med"},{"issue":"8","key":"3947_CR83","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/intimm\/dxw014","volume":"28","author":"S Spranger","year":"2016","unstructured":"Spranger S. Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment. Int Immunol. 2016;28(8):383\u201391. https:\/\/doi.org\/10.1093\/intimm\/dxw014.","journal-title":"Int Immunol"},{"issue":"7","key":"3947_CR84","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1111\/cas.14069","volume":"110","author":"Y Ohue","year":"2019","unstructured":"Ohue Y, Nishikawa H. Regulatory t (Treg) cells in cancer: can Treg cells be a new therapeutic target? Cancer Sci. 2019;110(7):2080\u20139. https:\/\/doi.org\/10.1111\/cas.14069.","journal-title":"Cancer Sci"},{"key":"3947_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116086","volume":"170","author":"Z Zhong","year":"2024","unstructured":"Zhong Z, Wang T, Zang R, Zang Y, Feng Y, Yan S, et al. Dual PI3K\/mTOR inhibitor PF-04979064 regulates tumor growth in gastric cancer and enhances drug sensitivity of gastric cancer cells to 5-FU. Biomed Pharmacother. 2024;170:116086. https:\/\/doi.org\/10.1016\/j.biopha.2023.116086.","journal-title":"Biomed Pharmacother"},{"issue":"810","key":"3947_CR86","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abo5213","volume":"16","author":"CW Wang","year":"2023","unstructured":"Wang CW, Cl\u00e9mot M, Hashimoto T, Diaz JA, Goins LM, Goldstein AS, et al. A conserved mechanism for JNK-mediated loss of Notch function in advanced prostate cancer. Sci Signal. 2023;16(810):eabo5213. https:\/\/doi.org\/10.1126\/scisignal.abo5213.","journal-title":"Sci Signal"},{"key":"3947_CR87","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2021.06.007","volume":"518","author":"V Koh","year":"2021","unstructured":"Koh V, Chakrabarti J, Torvund M, Steele N, Hawkins JA, Ito Y, et al. Hedgehog transcriptional effector GLI mediates mTOR-induced PD-L1 expression in gastric cancer organoids. Cancer Lett. 2021;518:59\u201371. https:\/\/doi.org\/10.1016\/j.canlet.2021.06.007.","journal-title":"Cancer Lett"},{"issue":"1","key":"3947_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-022-00099-8","volume":"3","author":"R Xia","year":"2022","unstructured":"Xia R, Xu M, Yang J, Ma X. The role of hedgehog and Notch signaling pathway in cancer. Mol Biomed. 2022;3(1):44. https:\/\/doi.org\/10.1186\/s43556-022-00099-8.","journal-title":"Mol Biomed"},{"issue":"1","key":"3947_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-023-00592-6","volume":"9","author":"S Zhai","year":"2023","unstructured":"Zhai S, Lin J, Ji Y, Zhang R, Zhang Z, Cao Y, et al. A microprotein N1DARP encoded by LINC00261 promotes Notch1 intracellular domain (N1ICD) degradation via disrupting USP10-N1ICD interaction to inhibit chemoresistance in Notch1-hyperactivated pancreatic cancer. Cell Discov. 2023;9(1):95. https:\/\/doi.org\/10.1038\/s41421-023-00592-6.","journal-title":"Cell Discov"},{"issue":"16","key":"3947_CR90","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1038\/s41388-022-02246-5","volume":"41","author":"WR Wu","year":"2022","unstructured":"Wu WR, Shi XD, Zhang FP, Zhu K, Zhang R, Yu XH, et al. Activation of the Notch1-c-Myc-VCAM1 signalling axis initiates liver progenitor cell-driven hepatocarcinogenesis and pulmonary metastasis. Oncogene. 2022;41(16):2340\u201356. https:\/\/doi.org\/10.1038\/s41388-022-02246-5.","journal-title":"Oncogene"},{"issue":"1","key":"3947_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-022-03013-8","volume":"5","author":"Y Nakano","year":"2022","unstructured":"Nakano Y, Nakao S, Sueoka M, Kasahara D, Tanno Y, Sumiyoshi H, et al. Two distinct Notch signals, delta-like 4\/Notch1 and Jagged-1\/Notch2, antagonistically regulate chemical hepatocarcinogenesis in mice. Commun Biol. 2022;5(1):85. https:\/\/doi.org\/10.1038\/s42003-022-03013-8.","journal-title":"Commun Biol"},{"issue":"1 Suppl","key":"3947_CR92","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/0023677215570086","volume":"49","author":"R Tolba","year":"2015","unstructured":"Tolba R, Kraus T, Liedtke C, Schwarz M, Weiskirchen R. Diethylnitrosamine (DEN)-induced carcinogenic liver injury in mice. Lab Anim. 2015;49(1 Suppl):59\u201369. https:\/\/doi.org\/10.1177\/0023677215570086.","journal-title":"Lab Anim"},{"issue":"3718","key":"3947_CR93","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1126\/science.152.3718.83","volume":"152","author":"MF Rajewsky","year":"1966","unstructured":"Rajewsky MF, Dauber W, Frankenberg H. Liver carcinogenesis by diethylnitrosamine in the rat. Science. 1966;152(3718):83\u20135. https:\/\/doi.org\/10.1126\/science.152.3718.83.","journal-title":"Science"},{"key":"3947_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.638763","volume":"12","author":"X Li","year":"2021","unstructured":"Li X, Wang Y, Li X, Feng G, Hu S, Bai Y. The impact of NOTCH pathway alteration on tumor microenvironment and clinical survival of immune checkpoint inhibitors in NSCLC. Front Immunol. 2021;12:638763. https:\/\/doi.org\/10.3389\/fimmu.2021.638763.","journal-title":"Front Immunol"},{"issue":"26","key":"3947_CR95","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202504054","volume":"12","author":"Z Zhou","year":"2025","unstructured":"Zhou Z, Gu Y, Yi Z, Wang J, Xiong Z, Guo H, et al. SNORA74A drives self-renewal of liver cancer stem cells and hepatocarcinogenesis through activation of Notch3 signaling. Adv Sci. 2025;12(26):2504054. https:\/\/doi.org\/10.1002\/advs.202504054.","journal-title":"Adv Sci"},{"issue":"5","key":"3947_CR96","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s11596-017-1794-9","volume":"37","author":"R Cheng","year":"2017","unstructured":"Cheng R, Cai X, Ke K, Chen Y. Notch4 inhibition suppresses invasion and vasculogenic mimicry formation of hepatocellular carcinoma cells. Curr Med Sci. 2017;37(5):719\u201325. https:\/\/doi.org\/10.1007\/s11596-017-1794-9.","journal-title":"Curr Med Sci"},{"issue":"3","key":"3947_CR97","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1142\/S0192415X17500343","volume":"45","author":"N Yao","year":"2017","unstructured":"Yao N, Ren K, Wang Y, Jin Q, Lu X, Lu Y, et al. Paris polyphylla suppresses proliferation and vasculogenic mimicry of human osteosarcoma cells and inhibits tumor growth in vivo. Am J Chin Med. 2017;45(3):575\u201398. https:\/\/doi.org\/10.1142\/S0192415X17500343.","journal-title":"Am J Chin Med"},{"issue":"4","key":"3947_CR98","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3892\/or.16.4.693","volume":"16","author":"B Sun","year":"2006","unstructured":"Sun B, Zhang S, Zhang D, Du J, Guo H, Zhao X, et al. Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma. Oncol Rep. 2006;16(4):693\u20138. https:\/\/doi.org\/10.3892\/or.16.4.693.","journal-title":"Oncol Rep"},{"issue":"1","key":"3947_CR99","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1158\/0008-5472.CAN-20-0256","volume":"81","author":"Y Geng","year":"2021","unstructured":"Geng Y, Fan J, Chen L, Zhang C, Qu C, Qian L, et al. A notch-dependent inflammatory feedback circuit between macrophages and cancer cells regulates pancreatic cancer metastasis. Cancer Res. 2021;81(1):64\u201376. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-0256.","journal-title":"Cancer Res"},{"issue":"2","key":"3947_CR100","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.201900503","volume":"4","author":"WC Chung","year":"2021","unstructured":"Chung WC, Challagundla L, Zhou Y, Li M, Atfi A, Xu K. Loss of Jag1 cooperates with oncogenic KRAS to induce pancreatic cystic neoplasms. Life Sci Alliance. 2021;4(2):e201900503. https:\/\/doi.org\/10.26508\/lsa.201900503.","journal-title":"Life Sci Alliance"},{"issue":"48","key":"3947_CR101","doi-asserted-by":"publisher","first-page":"18913","DOI":"10.1073\/pnas.0810097105","volume":"105","author":"N Habbe","year":"2008","unstructured":"Habbe N, Shi G, Meguid RA, Fendrich V, Esni F, Chen H, et al. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic KRAS in adult mice. Proc Natl Acad Sci. 2008;105(48):18913\u20138. https:\/\/doi.org\/10.1073\/pnas.0810097105.","journal-title":"Proc Natl Acad Sci"},{"issue":"49","key":"3947_CR102","doi-asserted-by":"publisher","first-page":"19327","DOI":"10.1073\/pnas.0705953104","volume":"104","author":"ET Sawey","year":"2007","unstructured":"Sawey ET, Johnson JA, Crawford HC. Matrix metalloproteinase 7 controls pancreatic acinar cell transdifferentiation by activating the notch signaling pathway. Proc Natl Acad Sci U S A. 2007;104(49):19327\u201332. https:\/\/doi.org\/10.1073\/pnas.0705953104.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"3947_CR103","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nm754","volume":"8","author":"S Weijzen","year":"2002","unstructured":"Weijzen S, Rizzo P, Braid M, Vaishnav R, Jonkheer SM, Zlobin A, et al. Activation of Notch-1 signaling maintains the neoplastic phenotype in human RAS-transformed cells. Nat Med. 2002;8(9):979\u201386. https:\/\/doi.org\/10.1038\/nm754.","journal-title":"Nat Med"},{"issue":"12","key":"3947_CR104","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.1172\/JCI45797","volume":"121","author":"E Maniati","year":"2011","unstructured":"Maniati E, Bossard M, Cook N, Candido JB, Emami-Shahri N, Nedospasov SA, et al. Crosstalk between the canonical NF-\u03baB and notch signaling pathways inhibits PPAR\u03b3 expression and promotes pancreatic cancer progression in mice. J Clin Invest. 2011;121(12):4685\u201399. https:\/\/doi.org\/10.1172\/JCI45797.","journal-title":"J Clin Invest"},{"issue":"11","key":"3947_CR105","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.1158\/0008-5472.CAN-09-4645","volume":"70","author":"L Hanlon","year":"2010","unstructured":"Hanlon L, Avila JL, Demarest RM, Troutman S, Allen M, Ratti F, et al. Notch1 functions as a tumor suppressor in a model of K-ras\u2013induced pancreatic ductal adenocarcinoma. Cancer Res. 2010;70(11):4280\u20136. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-4645.","journal-title":"Cancer Res"},{"issue":"12","key":"3947_CR106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052133","volume":"7","author":"JL Avila","year":"2012","unstructured":"Avila JL, Troutman S, Durham A, Kissil JL. Notch1 is not required for acinar-to-ductal metaplasia in a model of Kras-induced pancreatic ductal adenocarcinoma. PLoS ONE. 2012;7(12):e52133. https:\/\/doi.org\/10.1371\/journal.pone.0052133.","journal-title":"PLoS ONE"},{"issue":"9","key":"3947_CR107","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.neo.2021.07.008","volume":"23","author":"Y Capodanno","year":"2021","unstructured":"Capodanno Y, Chen Y, Schrader J, Tomosugi M, Sumi S, Yokoyama A, et al. Cross-talk among MEN1, p53 and Notch regulates the proliferation of pancreatic neuroendocrine tumor cells by modulating INSM1 expression and subcellular localization. Neoplasia. 2021;23(9):979\u201392. https:\/\/doi.org\/10.1016\/j.neo.2021.07.008.","journal-title":"Neoplasia"},{"issue":"1","key":"3947_CR108","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s12020-012-9850-5","volume":"44","author":"M Krausch","year":"2013","unstructured":"Krausch M, Kroepil F, Lehwald N, Lachenmayer A, Schott M, Anlauf M, et al. Notch 1 tumor expression is lacking in highly proliferative pancreatic neuroendocrine tumors. Endocrine. 2013;44(1):182\u20136. https:\/\/doi.org\/10.1007\/s12020-012-9850-5.","journal-title":"Endocrine"},{"issue":"5","key":"3947_CR109","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1136\/jclinpath-2012-201273","volume":"66","author":"K Harada","year":"2013","unstructured":"Harada K, Sato Y, Ikeda H, Hsu M, Igarashi S, Nakanuma Y. Notch1-Hes1 signalling axis in the tumourigenesis of biliary neuroendocrine tumours. J Clin Pathol. 2013;66(5):386\u201391. https:\/\/doi.org\/10.1136\/jclinpath-2012-201273.","journal-title":"J Clin Pathol"},{"key":"3947_CR110","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.734966","volume":"12","author":"S L\u00f3pez-L\u00f3pez","year":"2021","unstructured":"L\u00f3pez-L\u00f3pez S, Romero De \u00c1vila MJ, Hern\u00e1ndez De Le\u00f3n NC, Ruiz-Marcos F, Baladr\u00f3n V, Nueda ML, et al. NOTCH4 exhibits anti-inflammatory activity in activated macrophages by interfering with Interferon-\u03b3 and TLR4 signaling. Front Immunol. 2021;12:734966. https:\/\/doi.org\/10.3389\/fimmu.2021.734966.","journal-title":"Front Immunol"},{"issue":"6","key":"3947_CR111","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3233\/CBM-150533","volume":"15","author":"CG Zheng","year":"2015","unstructured":"Zheng CG, Chen R, Xie JB, Liu CB, Jin Z, Jin C. Immunohistochemical expression of Notch1, Jagged1, NF-\u03baB and MMP-9 in colorectal cancer patients and the relationship to clinicopathological parameters. Cancer Biomark. 2015;15(6):889\u201397. https:\/\/doi.org\/10.3233\/CBM-150533.","journal-title":"Cancer Biomark"},{"issue":"10","key":"3947_CR112","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191515","volume":"217","author":"J Varga","year":"2020","unstructured":"Varga J, Nicolas A, Petrocelli V, Pesic M, Mahmoud A, Michels BE, et al. AKT-dependent NOTCH3 activation drives tumor progression in a model of mesenchymal colorectal cancer. J Exp Med. 2020;217(10):e20191515. https:\/\/doi.org\/10.1084\/jem.20191515.","journal-title":"J Exp Med"},{"issue":"1","key":"3947_CR113","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12885-023-10526-w","volume":"23","author":"K Huang","year":"2023","unstructured":"Huang K, Luo W, Fang J, Yu C, Liu G, Yuan X, et al. Notch3 signaling promotes colorectal tumor growth by enhancing immunosuppressive cells infiltration in the microenvironment. BMC Cancer. 2023;23(1):55. https:\/\/doi.org\/10.1186\/s12885-023-10526-w.","journal-title":"BMC Cancer"},{"issue":"1","key":"3947_CR114","doi-asserted-by":"publisher","first-page":"6095","DOI":"10.7150\/thno.44147","volume":"10","author":"TT Liao","year":"2020","unstructured":"Liao TT, Lin CC, Jiang JK, Yang SH, Teng HW, Yang MH. Harnessing stemness and PD-L1 expression by AT-rich interaction domain-containing protein 3B in colorectal cancer. Theranostics. 2020;10(1):6095\u2013112. https:\/\/doi.org\/10.7150\/thno.44147.","journal-title":"Theranostics"},{"issue":"3","key":"3947_CR115","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1158\/2326-6066.CIR-20-0428","volume":"9","author":"L Wang","year":"2021","unstructured":"Wang L, Yu S, Chan ER, Chen KY, Liu C, Che D, et al. Notch-regulated dendritic cells restrain inflammation-associated colorectal carcinogenesis. Cancer Immunol Res. 2021;9(3):348\u201361. https:\/\/doi.org\/10.1158\/2326-6066.CIR-20-0428.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"3947_CR116","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1186\/s12885-022-10032-5","volume":"22","author":"F Wang","year":"2022","unstructured":"Wang F, Huang C, Long J, Zhao ZB, Ma HQ, Yao XQ, et al. Notch signaling mutations increase intra-tumor chemokine expression and predict response to immunotherapy in colorectal cancer. BMC Cancer. 2022;22(1):933. https:\/\/doi.org\/10.1186\/s12885-022-10032-5.","journal-title":"BMC Cancer"},{"key":"3947_CR117","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.2147\/JIR.S394894","volume":"16","author":"A Lin","year":"2023","unstructured":"Lin A, Yao J, Cheng Q, Liu Z, Luo P, Zhang J. Mutations status of NOTCH signaling pathway predict prognosis of immune checkpoint inhibitors in colorectal cancer. J Inflamm Res. 2023;16:1693\u2013709. https:\/\/doi.org\/10.2147\/JIR.S394894.","journal-title":"J Inflamm Res"},{"issue":"2","key":"3947_CR118","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1016\/j.bbagen.2012.11.008","volume":"1830","author":"C Karamboulas","year":"2013","unstructured":"Karamboulas C, Ailles L. Developmental signaling pathways in cancer stem cells of solid tumors. Biochim Biophys Acta Gen Subj. 2013;1830(2):2481\u201395. https:\/\/doi.org\/10.1016\/j.bbagen.2012.11.008.","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"3","key":"3947_CR119","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.critrevonc.2012.11.009","volume":"86","author":"WKK Wu","year":"2013","unstructured":"Wu WKK, Wang XJ, Cheng ASL, Luo MXM, Ng SSM, To KF, et al. Dysregulation and crosstalk of cellular signaling pathways in colon carcinogenesis. Crit Rev Oncol Hematol. 2013;86(3):251\u201377. https:\/\/doi.org\/10.1016\/j.critrevonc.2012.11.009.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"22","key":"3947_CR120","doi-asserted-by":"publisher","first-page":"5207","DOI":"10.1002\/cncr.25449","volume":"116","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Li B, Ji Z, Zheng P. Notch1 regulates the growth of human colon cancers. Cancer. 2010;116(22):5207\u201318. https:\/\/doi.org\/10.1002\/cncr.25449.","journal-title":"Cancer"},{"issue":"2","key":"3947_CR121","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/ijc.33562","volume":"149","author":"A Nadeem","year":"2021","unstructured":"Nadeem A, Aung KM, Ray T, Alam A, Persson K, Pal A, et al. Suppression of \u03b2-catenin signaling in colon carcinoma cells by a bacterial protein. Int J Cancer. 2021;149(2):442\u201359. https:\/\/doi.org\/10.1002\/ijc.33562.","journal-title":"Int J Cancer"},{"issue":"8057","key":"3947_CR122","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41586-024-08573-9","volume":"640","author":"L Gaynor","year":"2025","unstructured":"Gaynor L, Singh H, Tie G, Badarinath K, Madha S, Mancini A, et al. Crypt density and recruited enhancers underlie intestinal tumour initiation. Nature. 2025;640(8057):231\u20139. https:\/\/doi.org\/10.1038\/s41586-024-08573-9.","journal-title":"Nature"},{"issue":"3","key":"3947_CR123","doi-asserted-by":"publisher","first-page":"227","DOI":"10.7150\/thno.10185","volume":"5","author":"CM Lewis","year":"2015","unstructured":"Lewis CM, Graves SA, Hernandez R, Valdovinos HF, Barnhart TE, Cai W, et al. 52Mn production for PET\/MRI tracking of human stem cells expressing divalent metal transporter 1 (DMT1). Theranostics. 2015;5(3):227\u201339. https:\/\/doi.org\/10.7150\/thno.10185.","journal-title":"Theranostics"},{"issue":"24","key":"3947_CR124","doi-asserted-by":"publisher","first-page":"5811","DOI":"10.1111\/febs.16946","volume":"290","author":"J Hounjet","year":"2023","unstructured":"Hounjet J, Groot AJ, Piepers JP, Kranenburg O, Zwijnenburg DA, Rapino FA, et al. Iron-responsive element of divalent metal transporter 1 (Dmt1) controls Notch-mediated cell fates. FEBS J. 2023;290(24):5811\u201334. https:\/\/doi.org\/10.1111\/febs.16946.","journal-title":"FEBS J"},{"key":"3947_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.03.003","volume":"508","author":"X Wang","year":"2021","unstructured":"Wang X, Chen H, Jiang R, Hong X, Peng J, Chen W, et al. Interleukin-17 activates and synergizes with the Notch signaling pathway in the progression of pancreatic ductal adenocarcinoma. Cancer Lett. 2021;508:1\u201312. https:\/\/doi.org\/10.1016\/j.canlet.2021.03.003.","journal-title":"Cancer Lett"},{"issue":"10","key":"3947_CR126","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/s41419-019-2023-1","volume":"10","author":"B Yang","year":"2019","unstructured":"Yang B, Wang C, Xie H, Wang Y, Huang J, Rong Y, et al. MicroRNA-3163 targets ADAM-17 and enhances the sensitivity of hepatocellular carcinoma cells to molecular targeted agents. Cell Death Dis. 2019;10(10):784. https:\/\/doi.org\/10.1038\/s41419-019-2023-1.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3947_CR127","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12967-019-1876-5","volume":"17","author":"M Moghbeli","year":"2019","unstructured":"Moghbeli M, Mosannen Mozaffari H, Memar B, Forghanifard MM, Gholamin M, Abbaszadegan MR. Role of MAML1 in targeted therapy against the esophageal cancer stem cells. J Transl Med. 2019;17(1):126. https:\/\/doi.org\/10.1186\/s12967-019-1876-5.","journal-title":"J Transl Med"},{"issue":"5","key":"3947_CR128","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/cac2.12416","volume":"43","author":"A Goenka","year":"2023","unstructured":"Goenka A, Khan F, Verma B, Sinha P, Dmello CC, Jogalekar MP, et al. Tumor microenvironment signaling and therapeutics in cancer progression. Cancer Commun. 2023;43(5):525\u201361. https:\/\/doi.org\/10.1002\/cac2.12416.","journal-title":"Cancer Commun"},{"issue":"11","key":"3947_CR129","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116296","volume":"23","author":"A Chimento","year":"2022","unstructured":"Chimento A, D\u2019Amico M, Pezzi V, De Amicis F. Notch signaling in breast tumor microenvironment as mediator of drug resistance. Int J Mol Sci. 2022;23(11):6296. https:\/\/doi.org\/10.3390\/ijms23116296.","journal-title":"Int J Mol Sci"},{"issue":"22","key":"3947_CR130","doi-asserted-by":"publisher","first-page":"16505","DOI":"10.3390\/ijms242216505","volume":"24","author":"NN Al-Bzour","year":"2023","unstructured":"Al-Bzour NN, Al-Bzour AN, Ababneh OE, Al-Jezawi MM, Saeed A, Saeed A. Cancer-associated fibroblasts in gastrointestinal cancers: unveiling their dynamic roles in the tumor microenvironment. Int J Mol Sci. 2023;24(22):16505. https:\/\/doi.org\/10.3390\/ijms242216505.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"3947_CR131","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15092513","volume":"15","author":"SH Cheng","year":"2023","unstructured":"Cheng SH, Chiou HYC, Wang JW, Lin MH. Reciprocal regulation of cancer-associated fibroblasts and tumor microenvironment in gastrointestinal cancer: implications for cancer dormancy. Cancers. 2023;15(9):2513. https:\/\/doi.org\/10.3390\/cancers15092513.","journal-title":"Cancers"},{"issue":"13","key":"3947_CR132","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133434","volume":"15","author":"SP Papadakos","year":"2023","unstructured":"Papadakos SP, Stergiou IE, Gkolemi N, Arvanitakis K, Theocharis S. Unraveling the significance of EPH\/ephrin signaling in liver cancer: insights into tumor progression and therapeutic implications. Cancers. 2023;15(13):3434. https:\/\/doi.org\/10.3390\/cancers15133434.","journal-title":"Cancers"},{"issue":"1","key":"3947_CR133","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02536-6","volume":"41","author":"S Mancarella","year":"2022","unstructured":"Mancarella S, Gigante I, Serino G, Pizzuto E, Dituri F, Valentini MF, et al. Crenigacestat blocking Notch pathway reduces liver fibrosis in the surrounding ecosystem of intrahepatic CCA via TGF-\u03b2 inhibition. J Exp Clin Cancer Res. 2022;41(1):331. https:\/\/doi.org\/10.1186\/s13046-022-02536-6.","journal-title":"J Exp Clin Cancer Res"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-026-03947-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-03947-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-03947-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:14:55Z","timestamp":1771424095000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-026-03947-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":133,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3947"],"URL":"https:\/\/doi.org\/10.1186\/s40001-026-03947-3","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"328"}}